Boston Scientific accounts are for healthcare professionals only.
Join our events
Breakfast Symposium
Advancing Treatment Options for Chronic Focal Neuropathic Pain
Learn how the Nalu™ System† for Peripheral Nerve Stimulation (PNS) delivers long-term, personalized pain relief and functional improvements with its unique design and advanced programming capabilities.
Friday, July 17 from 7:00-7:45am
Fontainebleau Miami Beach
Glimmer 1-4
Presented by Lindsay Carter, MSN, FNP-C,* John Hatheway, MD,* and Evan Peskin, MD, MBA*
Moderated by Eric Cornidez, MD, MBA*
Opening remarks by Jim Cassidy, SVP & President, Neuromodulation, Boston Scientific
Lunch Symposium
Boston Scientific: Advancing Science for the Future of Interventional Pain Care
Discover the breakthrough innovations and evidence that are shaping the next era of interventional pain therapies, plus hear experts address your questions live.
Friday, July 17 from 12:00-1:00pm
Fontainebleau Miami Beach
Glimmer 5-7
Presented by Eric Cornidez, MD, MBA,* Michael Esposito, MD,* Manny Gage, MD,* and Ramana Naidu, MD*
Moderated by Soriaya Motivala, MD*
Visit our booths
Explore the Boston Scientific pain portfolio
Stop by Booth #9A to explore our latest advancements in interventional pain care, including an interactive simulation of the Intracept Procedure.
Hands-on demonstration and procedural guidance with the Nalu System
Join an interactive experience where you can observe and practice procedural techniques, ask questions, and gain insights into the versatility of the Nalu System. Learn directly from experts and explore best practices in real time.
Friday, July 17 from 10:20-10:40am and 1:50-2:20pm
Exhibit Hall – Booth #1A
Expert guidance from Lindsay Carter, MSN, FNP-C,* Eric Cornidez, MD, MBA,* John Hatheway, MD,* Evan Peskin, MD,* and Omar Viswanath, MD*
Coffee break with our team
Stop by our booth for coffee, and connect with our team to learn more about the Nalu System.
Saturday, July 18 from 9:40-10:00am
Exhibit Hall – Booth #1A
Clinical and scientific data presentations
Oral Presentations
Real-World Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control - USA Experience
Real-World Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients
Characterizing Time to Depletion in Multiple-Independent Current-Controlled Rechargeable Implantable Pulse Generators for Deep Brain Stimulation
ASPN top abstract presentations
Intraosseous Basivertebral Nerve Ablation for Chronic Vertebrogenic Pain: Real-world Outcomes from the IMPROVE Prospective Multicenter Study
Friday, July 17
10:45-10:55am
Fontaine Ballroom
Presented by Ramana Naidu, MD
Three-Year Outcomes of Spinal Cord Stimulation Across Multiple Indications: A Prospective, Global, Real-world Registry
Sunday, July 19
11:20-11:30am
Fontaine Ballroom
Interim Long-term Pain and Functional Outcomes from the COMFORT Peripheral Nerve Stimulation Randomized Control Trial
Sunday, July 19
11:30-11:40am
Fontaine Ballroom
Presented by John Hatheway, MD
E-poster Presentations
Long-term Spinal Cord Stimulation Outcomes Using Fast-Acting Sub-perception Therapy Designed to Engage Surround Inhibition
Anitescu et al.
Long-Term Real-World Outcomes of Fast-Acting Sub-perception Spinal Cord Stimulation in a Multinational Cohort across Europe and the United States
Bayerl, Metzger et al.
Real-World Outcomes of Radiofrequency Ablation for Chronic Low Back Pain Using a Novel Large-Lesion Cannula Design
Bayerl et al.
Three-year Outcomes of SCS Across Multiple Indications: A Prospective, Global, Real-World Registry
Berg et al.
Peripheral Nerve Stimulation with Micro-IPG for the Treatment of Chronic Pain After Total Knee Arthroplasty
Engle et al.
Spinal Cord Stimulation Plus Conventional Medical Management Versus Conventional Medical Management Alone for Severe, Non-Surgical, Refractory Back Pain: 24-Month Outcomes from the SOLIS Randomized Clinical Trial
Guirguis et al.
Interim Long-Term Pain and Functional Outcomes from the COMFORT Peripheral Nerve Stimulation Randomized Control Trial
Hatheway et al.
Re-establishing Efficacy in Chronic SCS Therapy Through Standardized Connector and Adaptor Systems
Hussain et al.
Real-World Multicenter Outcomes of Novel 16-Contact Percutaneous Leads and Multimodal Spinal Cord Stimulation for Chronic Pain
Kallewaard et al.
Intraosseous Basivertebral Nerve Ablation for Chronic Vertebrogenic Pain: Real-world Outcomes from the IMPROVE Prospective Multicenter Study
Naidu et al.
†Nalu™ Neurostimulation System
*The noted individual(s) serves as a consultant to Boston Scientific and is compensated for services provided under a consulting agreement.
1. Gage E., et al. Rapid Onset of Analgesia during Trial Period Utilizing Fast-Acting Sub-Perception Therapy SCS [Abstract] NANS 2023 Annual Meeting, Jan 12-15, 2023.
2. Anitescu M., et al. Utilizing SCS Designed to Engage Surround Inhibition Using Fast-Acting Sub-Perception Therapy (FAST): Prospective, Multicenter, Long-Term Outcomes [Abstract] NANS 2025 Annual Meeting, Jan 30-Feb1, 2025.
3. Metzger C, Hammond B, Ferro R, North J, Pyles S, Kranenburg A, Washabaugh E, Goldberg E. Two-year outcomes using fast-acting sub-perception therapy for spinal cord stimulation: results of a real-world multicenter study in the United States. Expert Rev Med Devices. 2025 Jan-Feb;22(2):155-164.
4. Bayerl S, Paz-Solis J, Matis G, et al. Two-year outcomes using fast-acting, sub-perception therapy for spinal cord stimulation: a European, real-world, multicenter experience. JCM. 2024;13(22):6999
5. Ferro R, North J, Kranenburg A, et al. Automated neural dosing for fast-acting subperception therapy: sustained spinal cord stimulation outcomes from a multicenter study. Pain Ther.2025;14(4):1417-1429.
6. Engle MP, Hersel A, Gutierrez G, Khemlani V, Kapural L, et al. (2026) Long-Term Clinical Outcomes (24 Months) of Peripheral Nerve Stimulation in the Treatment of Chronic Pain - COMFORT RCT. Chron Pain Manag 10: 179. DOI: 10.29011/2576-957X.100079
7. Fischgrund J, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-34. doi.org/10.1007/s00586-020-06448-x
U.S. Federal Government Employees – U.S. Federal Government Employees may be required to obtain approval from their agency's or institution's ethics officer or ethics committee or from a supervisor to attend this program. For more details, please contact your ethics officer or supervisor.
Vermont-Licensed HCPs – Vermont law prohibits Boston Scientific from providing any food, meals or refreshments at no charge to health care professionals licensed by and regularly practicing in Vermont. Accordingly, health care professionals licensed by and regularly practicing in Vermont are requested not to partake in any of the food, meals or refreshments offered at this event.
All U.S. Physicians – The U.S. Physician Payment Sunshine Act requires all pharmaceutical, biologics, and medical device companies to disclose annually to the U.S. government payments and transfers of value provided to U.S. physicians and teaching hospitals. This includes the value of meals and refreshments provided to U.S. physicians in connection with attending Boston Scientific educational programs.
Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.
Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population.
View Boston Scientific Spinal Cord Stimulator System Indications, Safety, and Warnings
View Boston Scientific Nalu Neurostimulation System Indications, Safety, and Warnings
View Boston Scientific Radiofrequency Ablation Indications, Safety, and Warnings